PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.

MLA

Ayhan Ozcan, et al. “PAX-2 in the Diagnosis of Primary Renal Tumors: Immunohistochemical Comparison with Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin.” American Journal of Clinical Pathology, vol. 131, no. 3, Mar. 2009, pp. 393–404. EBSCOhost, https://doi.org/10.1309/AJCPM7DW0XFHDHNY.

APA

Ayhan Ozcan, Jim Zhai, Candice Hamilton, Steven S Shen, Jae Y Ro, Bhuvaneswari Krishnan, & Luan D Truong. (2009). PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. American Journal of Clinical Pathology, 131(3), 393–404. https://doi.org/10.1309/AJCPM7DW0XFHDHNY

Chicago

Ayhan Ozcan, Jim Zhai, Candice Hamilton, Steven S Shen, Jae Y Ro, Bhuvaneswari Krishnan, and Luan D Truong. 2009. “PAX-2 in the Diagnosis of Primary Renal Tumors: Immunohistochemical Comparison with Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin.” American Journal of Clinical Pathology 131 (3): 393–404. doi:10.1309/AJCPM7DW0XFHDHNY.